Related Experiment Video
Updated: Sep 9, 2025

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects
Xueni Lu1,2, Jianlin Zhou1,2, Yi Ming1,2
1The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China.
Abstract:
Invasive fungal infections (IFIs) have become prominent global health threats, escalating the burden on public health systems. The increasing occurrence of invasive fungal infections is due primarily to the extensive application of chemotherapy, immunosuppressive therapies, and broad-spectrum antifungal agents. At present, therapeutic practices utilize multiple categories of antifungal agents, such as azoles, polyenes, echinocandins, and pyrimidine analogs. Nevertheless, the clinical effectiveness of these treatments is progressively weakened by the emergence of drug resistance, thereby substantially restricting their therapeutic utility. Consequently, there is an imperative need to expedite the discovery of novel antifungal agents. This review seeks to present an exhaustive synthesis of novel antifungal drugs and candidate agents that are either under current clinical investigation or anticipated to progress into clinical evaluation. These emerging compounds exhibit unique benefits concerning their modes of action, antimicrobial spectra, and pharmacokinetic characteristics, potentially leading to improved therapeutic outcomes relative to conventional antifungal regimens. It is anticipated that these novel therapeutic agents will furnish innovative treatment modalities and enhance clinical outcomes in managing invasive fungal infections.
Insights
New antifungal drugs are urgently needed due to rising invasive fungal infections (IFIs) and drug resistance. This review synthesizes emerging antifungal agents in clinical trials, offering hope for improved treatment outcomes against resistant fungal pathogens.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Invasive fungal infections (IFIs) pose a significant global health challenge, exacerbated by increased use of chemotherapy and immunosuppressive therapies.
- Current antifungal treatments (azoles, polyenes, echinocandins, pyrimidine analogs) face limitations due to emerging drug resistance, reducing clinical efficacy.
- There is a critical need for novel antifungal agents to combat the growing threat of IFIs.
Purpose of the Study:
- To provide a comprehensive review of novel antifungal drugs and candidate agents currently in clinical investigation or development.
- To highlight emerging compounds with unique mechanisms of action, broader antimicrobial spectra, and improved pharmacokinetic profiles.
- To assess the potential of these novel agents to overcome existing therapeutic limitations and enhance outcomes for invasive fungal infections.
Main Methods:
- Literature review of preclinical and clinical studies on emerging antifungal agents.
- Synthesis of data on novel drug candidates, including their mechanisms of action, spectrum of activity, and pharmacokinetic properties.
- Analysis of the potential clinical utility and therapeutic advantages over existing antifungal regimens.
Main Results:
- Identification of several novel antifungal drug candidates progressing through clinical evaluation.
- These agents demonstrate diverse mechanisms of action, potentially circumventing existing resistance pathways.
- Emerging compounds show promise for broader spectrum activity and enhanced pharmacokinetic profiles compared to standard therapies.
Conclusions:
- Novel antifungal agents are essential to address the increasing burden of invasive fungal infections and antifungal resistance.
- The reviewed candidate drugs represent promising therapeutic options with the potential to improve treatment outcomes.
- Continued research and clinical evaluation of these novel agents are crucial for advancing the management of invasive fungal infections.
Related Concept Videos
Antimicrobial Effectiveness
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Microorganisms in Medicine and Therapeutics
Gene Regulation in Microbial Communities: Quorum Sensing
Overview of Fungi
Fungal Phylum Microsporidia

